Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
CME in Minutes: Education in Oncology & Hematology - Paul Telfer, MA, DM, BM, BCh, FRCP, FRCPath - Decoding the Future: Bringing Gene Therapy Into Prime Time for Patients With Sickle Cell Disease

Paul Telfer, MA, DM, BM, BCh, FRCP, FRCPath - Decoding the Future: Bringing Gene Therapy Into Prime Time for Patients With Sickle Cell Disease

CME in Minutes: Education in Oncology & Hematology

07/04/24 • 13 min

plus icon
bookmark
Share icon
Please visit answersincme.com/HRY860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in hematology discusses the use of gene therapy for the treatment of sickle cell disease (SCD). Upon completion of this activity, participants should be better able to: Identify the rationale for the use of gene therapy in sickle cell disease; Review the clinical significance of the latest trial data for gene therapy in sickle cell disease; and Outline considerations to optimize the use of gene therapy in patients with sickle cell disease.

07/04/24 • 13 min

plus icon
bookmark
Share icon

Generate a badge

Get a badge for your website that links back to this episode

Select type & size
Open dropdown icon
share badge image

<a href="https://goodpods.com/podcasts/cme-in-minutes-education-in-oncology-and-hematology-449630/paul-telfer-ma-dm-bm-bch-frcp-frcpath-decoding-the-future-bringing-gen-61310782"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to paul telfer, ma, dm, bm, bch, frcp, frcpath - decoding the future: bringing gene therapy into prime time for patients with sickle cell disease on goodpods" style="width: 225px" /> </a>

Copy